REPL vs BIIB: Which Stock is Better?
Side-by-side comparison of Replimune Group Inc and Biogen Inc in 2026
REPL
Replimune Group Inc
—
BIIB
Biogen Inc
$199.59
Key Metrics Comparison
| Metric | REPL | BIIB | Winner |
|---|---|---|---|
| Market Cap | $825.73M | $29.33B | BIIB |
| P/E Ratio | N/A | 21.39 | BIIB |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze REPL
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REPL or BIIB a better investment?
Comparing REPL and BIIB: Replimune Group Inc has a market cap of $825.73M while Biogen Inc has $29.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REPL and BIIB?
REPL (Replimune Group Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REPL or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: REPL or BIIB?
Both REPL and BIIB show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: REPL or BIIB?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: REPL or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $29.33B compared to $825.73M for REPL.
Should I buy REPL or BIIB in 2026?
Both REPL and BIIB have investment merit. REPL trades at $N/A while BIIB trades at $199.59. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REPL and BIIB stock?
Key differences: Market Cap ($825.73M vs $29.33B), P/E Ratio (N/A vs 21.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy REPL or BIIB in 2026?
The choice between REPL and BIIB depends on your investment goals. BIIB shows higher revenue growth (0.0%). BIIB has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between REPL and BIIB?
REPL (Replimune Group Inc) has a market cap of $825.73M, while BIIB (Biogen Inc) has a market cap of $29.33B. BIIB is the larger company by market value.